Toralgen
New Haven, US · 1 known investors
Find your way into Toralgen
36 people in our graph share verified history with the Toralgen team — schools, employers, funds. One of them is your warm intro.
Dan Brunnerunlockedknows Gerald Rea · together at Rose-Hulman Institute of Technology (overlapped)
×11knows the team · via Rose-Hulman Institute of Technology
Toralgen is a preclinical biopharmaceutical company developing oral drug delivery treatments for diabetes and autoimmune disorders using a poly-bile nanoparticle platform technology licensed from Yale University research.
Founders & leadership
TF
Tarek FahmyInventor and Co-founder
GR
Gerald ReainCEOGerald Rea is CEO of Toralgen, a biopharmaceutical company developing oral drug delivery treatments for diabetes and autoimmune disorders. He previously led Stray Light Optical Technologies as CEO and worked at Rose-Hulman Ventures on medical equipment and optical sensors; he holds degrees in optical and mechanical engineering from Rose-Hulman Institute of Technology and has collaborated with Yale University researchers since 2014 on pharmaceutical nanoplatform development.
JL
John LeeDirector of Development
Investors · 1
In the news
Frequently asked questions
- What does Toralgen do?
- Toralgen is a preclinical biopharmaceutical company developing oral drug delivery treatments for diabetes and autoimmune disorders using a poly-bile nanoparticle platform technology licensed from Yale University research.
- Who founded Toralgen?
- Toralgen was founded by Tarek Fahmy.
- Who are Toralgen's investors?
- Toralgen's investors include Elevate Ventures.
- Where is Toralgen headquartered?
- Toralgen is headquartered in New Haven, US.